Unigene Laboratories, Inc. Completes Executive Management Team and Names Jenene D. Thomas, VP of Investor Relations and Corporate Communications

BOONTON, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, announced today the appointment of Jenene D. Thomas to the newly created position of Vice President of Investor Relations and Corporate Communications. Ms. Thomas will report directly to Unigene’s President and Chief Executive Officer, Ashleigh Palmer. Her appointment is effective immediately.
MORE ON THIS TOPIC